WINSTON-SALEM, NC – JAN. 20, 2020 – A patient-specific tumor organoid platform developed by Wake Forest Institute for Regenerative Medicine (WFIRM) researchers and their cancer center colleagues could someday take the guessing game out of immunotherapy treatments. The hope is that, one day, these tumor organoids will be used […]
View Original Source at Changing cancer care, one organoid at a time